In vitro neutralization assay using cultured hepatitis C virus

Jannick Prentoe, Jens Bukh*

*Corresponding author for this work
    4 Citations (Scopus)

    Abstract

    The method outlined here enables evaluation of the neutralization potency of monoclonal and polyclonal antibodies against in vitro cultured hepatitis C virus (HCV). The high variation in envelope protein sequence among HCV isolates necessitates the inclusion of several isolates, spanning the major genotypes of HCV, in order to make strong conclusions concerning the cross-reactive neutralization potential of a given antibody. This would be particularly relevant for any neutralization experiments aimed at uncovering novel therapeutic- or vaccine-relevant antibodies. In addition, these assays can also be used to compare neutralization sensitivity of novel cultured HCV to that of previously characterized isolates.

    Original languageEnglish
    Title of host publicationHepatitis C Virus Protocols
    Number of pages7
    PublisherHumana Press
    Publication date2019
    Pages433-439
    ISBN (Print)978-1-4939-8975-1
    ISBN (Electronic)978-1-4939-8976-8
    DOIs
    Publication statusPublished - 2019
    SeriesMethods in Molecular Biology
    Volume1911
    ISSN1064-3745

    Keywords

    • Antibodies
    • HCV
    • Hepatitis C virus
    • Immunostaining
    • Neutralization
    • Vaccine

    Fingerprint

    Dive into the research topics of 'In vitro neutralization assay using cultured hepatitis C virus'. Together they form a unique fingerprint.

    Cite this